Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBEC0101 vs Enbrel in Rheumatoid Arthritis
NCT02357069Phase 3Unknown
- Sponsor
- LG Chem
- Start
- Feb 2015
- Primary completion
- Dec 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of etanercept in rheumatoid arthritis (RA) (2 arms), sponsored by LG Chem. Primary endpoint: Disease Activity Score based on a 28 joint count at 24 weeks. Status: unknown.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02357069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357069.